Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ASEP Medical HoldingsXCNQ:ASEP 19 Market Cap is C$2.06 Mil as of Jul. 25, 2026. GuruFocus rates XCNQ:ASEP with a GF Score™ of 19/100. The stock has 4 warning signs investors should review. Among 1,423 Biotechnology companies, ASEP Medical Holdings ranks worse than 96.98% on this metric.
ASEP Medical Holdings's quarterly market cap
declined
from Sep. 2025 (C$5.56 Mil) to Dec. 2025 (C$3.11 Mil) but then
increased
from Dec. 2025 (C$3.11 Mil) to Mar. 2026 (C$3.46 Mil).
ASEP Medical Holdings's annual market cap
declined
from Dec. 2023 (C$15.21 Mil) to Dec. 2024 (C$4.27 Mil) and
declined
from Dec. 2024 (C$4.27 Mil) to Dec. 2025 (C$3.11 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. ASEP Medical Holdings's Enterprise Value for Today is C$4.19 Mil.
ASEP Medical Holdings (XCNQ:ASEP) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XCNQ:ASEP vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, ASEP Medical Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ASEP Medical Holdings Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ASEP Medical Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where ASEP Medical Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
ASEP Medical Holdings's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASEP Medical Holdings (XCNQ:ASEP) has a Market Cap of C$2.06 Mil as of Jul. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on ASEP Medical Holdings and its competitors. According to the industry distribution chart, ASEP Medical Holdings ranks #1380 out of 1423 companies in the Biotechnology industry, placing it in the top 97%.
Is ASEP Medical Holdings' Market Cap too high?
ASEP Medical Holdings' current Market Cap is C$2.06 Mil. Based on the distribution chart, ASEP Medical Holdings ranks #1380 out of 1423 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, ASEP Medical Holdings has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does ASEP Medical Holdings' Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, ASEP Medical Holdings ranks #1380 out of 1423 companies for Market Cap. This places ASEP Medical Holdings in the lower half of its industry. The industry median Market Cap is 112.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 112.84, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on ASEP Medical Holdings and its competitors. For the Biotechnology industry, the median Market Cap is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ASEP Medical Holdings's current Market Cap is C$2.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASEP Medical Holdings stock overvalued right now?
ASEP Medical Holdings (XCNQ:ASEP) has a current Market Cap of C$2.06 Mil. The current Market Cap is C$2.06 Mil. ASEP Medical Holdings' overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For ASEP Medical Holdings (XCNQ:ASEP), the current Market Cap is C$2.06 Mil as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ASEP Medical Holdings Inc is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. Diagnostic and therapeutic solutions represent tremendous clinical and commercial potential, through rapid diagnostics and uniquely effective treatments. Its Diagnostic has developed a novel diagnostic assay for the early and rapid risk assessment of sepsis. Therapeutic offering: Patented peptide technology targets infection-causing biofilms and reduces inflammation.
19GF Score
Get the complete analysis for XCNQ:ASEP
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XCNQ:ASEP has been successfully added to your 
